IngentaConnect Clinical Trials and the Real World: Selection Bias and Generalisa...

Author: Sharpe N.¹

Source: Cardiovascular Drugs and Therapy, Volume 16, Number 1, January 2002 , pp. 75-77(3)

Publisher: Springer

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax Refund Policy

Abstract:

The clinical effectiveness movement underpins a major health professional culture change which is occurring worldwide. Clinical practice guidelines are an important component of this movement and seek to promote evidence-based care, and combine quality and efficiency with equity of access in a patient centred approach. However some areas of practice are more amenable to guidelines than others and may thus be advantaged in terms of resource allocation. While high grade evidence from randomised controlled trials forms the basis for many cardiovascular guidelines, selection bias may considerably limit the generalisability of such data. This is particularly exemplified by clinical trials in heart failure which are not necessarily relevant to the majority of older patients with heart failure in the community. Future research in heart failure should be oriented towards the community and realigned in the context of health care priorities for the more elderly who have yet to benefit from previous advances.

Keywords: clinical effectiveness; clinical trials; clinical practice guidelines

Language: English

Document Type: Regular paper

Affiliations: 1: School of Medicine, University of Auckland, Auckland, New Zealand. n.sharpe@auckland.ac.nz

Clinical Trials and the Real World: Selection Bias and Generalisability of Trial Results